EXHIBIT
13.1
CERTIFICATION
PURSUANT TO
18
U.S.C. §1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of
Lorus Therapeutics Inc. (the “Company”) on Form 20-F for the period ended May
31, 2008, as filed with the Securities and Exchange Commission on the date
hereof (the “Report”), I, Aiping H. Young, President and Chief Executive Officer
of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my
knowledge:
1.
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
Date:
November 26, 2008
/s/ Aiping H.
Young
Aiping
H. Young
President
and Chief Executive Officer